drugset / Trial / NCT03646318

Ketanserin Effects on Peripheral Temperature and Lactate

NCT03646318

RandomizedParallel-groupQuadruple-blindTreatment

Summary

A high blood lactate and a high peripheral to central temperature difference (deltaT) are associated with a higher mortality in critically ill patients. Both measures are signs of a reduced microcirculatory bloodflow or vasoconstriction and are associated with shock. It is unknown which medication can best be used to improve deltaT and lactate clearance. Ketanserin is being used in the intensive care setting for decades to optimize circulatory parameters. Ketanserin is a serotonin type 2-receptor blocker (5-HT2). Blocking the 5-HT2 receptor with ketanserin can attenuate pathological vasoconstriction. In these ways ketanserin can reduce vasoconstriction and can improve the microcirculation. As a consequence, the enhanced blood flow in the skin will increase the peripheral temperature and decrease deltaT. At the same time an increased flow in the microcirculation may lead to a reduction in lactate production. Objective: To determine the effects of a continuous ketanserin infusion on peripheral temperature and lactate clearance in critically ill patients with either a high lactate or a high deltaT.

Timeline

Start
2018-09-01
Primary completion
2019-04-01
Completion
2019-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketanserin Small molecule 0.75 ug/kg

Indications

No indication recorded.